Early treatment with corticosteroids in patients with Mycoplasma pneumoniae pneumonia: A randomized clinical trial

Journal of Tropical Pediatrics

Volumn 60, Issue 5, 2014, Pages 338-342

  Huang, Lizhen ^a   Gao, Xiang ^a   Chen, Meiyuan ^a  

^a Wujiang First Hospital   (China)

Author keywords

Corticosteroids; Mycoplasma pneumoniae pneumonia

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISOLONE;

ARTICLE; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; FEVER; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; COMPLICATION; DRUG EFFECTS; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; PATHOLOGY; PNEUMONIA, MYCOPLASMA; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TIME;

ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84930903192     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmu022     Document Type: Article

References (15)

1. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004; 113:701-7.
2. Nolevaux G, Bessaci-Kabouya K, Villenet N, et al. Epidemiological and clinical study of Mycoplasma pneumoniae respiratory infections in children hospitalized in a pediatric ward between 1999 and 2005 at the Reims University Hospital [in French]. Arch Pediatr 2008;15:1630-6.
3. Chiang WC, Teoh OH, Chong CY, et al. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Respirology 2007; 12:254-61.
4. Lee KY, Lee HS, Hong JH, et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 2006;41:263-8.
5. Tamura A, Matsubara K, Tanaka T, et al. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect 2008;57:223-8.
6. Liang H, Jiang W, Han Q, et al. Ciliary ultrastructural abnormalities in Mycoplasma pneumoniae pneumonia in 22 pediatric patients. Eur J Pediatr 2012;171:559-63.
7. Lu A, Wang L, Zhang X, et al. Combined treatment for child refractory Mycoplasma pneumoniae pneumonia with ciprofloxacin and glucocorticoid. Pediatr Pulmonol 2011;46:1093-7.
8. Bradley JS, Byington CL, Shah SS, et al. Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011;53:617-30.
9. Campbell MJ, Gardner MJ. Calculating confidence intervals for some non-parametric analyses. Br Med J (Clin Res Ed) 1988;296:1454-6.
10. Yang J, Hooper WC, Phillips DJ, et al. Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev 2004;15:157-68.
11. Hardy RD, Jafri HS, Olsen K, et al. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile. Infect Immun 2001;69:3869-76.
12. Opitz O, Pietsch K, Ehlers S, et al. Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response. Immunobiology 1996;196:575-87.
13. Tagliabue C, Salvatore CM, Techasaensiri C, et al. The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection. J Infect Dis 2008;198:1180-8.
14. Hirao S, Wada H, Nakagaki K, et al. Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone. FEMS Immunol Med Microbiol 2011;62:182-9.
15. Yende S, D'Angelo G, Kellum JA, et al. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008;177:1242-7.